Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 461-466

  Kloppenborg, Raoul P ^a,b   Nederkoorn, Paul J ^a   van der Graaf, Yolanda ^b   Geerlings, Mirjam I ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Cerebral small vessel disease; Cerebrovascular disease; Homocysteine; Lacunar infarct; White matter lesion

Indexed keywords

HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN DAMAGE; BRAIN INFARCTION; CEREBRAL SMALL VESSEL DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; LACUNAR INFARCT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER LESION;

AGED; ATHEROSCLEROSIS; BRAIN; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 79958012936     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.027     Document Type: Article

References (29)

1. Wong T.Y., Klein R., Sharrett A.R., ARIC Investigators, et al. Atheroslerosis Risk in Communities Study. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002, 288:67-74.
2. Silbert L.C., Nelson C., Howieson D.B., et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008, 71:108-113.
3. Hassan A., Hunt B.J., O'Sullivan M., et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003, 126:424-432.
4. Wardlaw J.M., Sandercock P.A., Dennis M.S., et al. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 2003, 34:806-812.
5. Spence J.D. Homocysteine-lowering therapy: a role in stroke prevention?. Lancet Neurol 2007, 6:830-838.
6. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double blind, parallel, placebo-controlled trial. Lancet Neurol 2010, 9:855-865. The VITATOPS Trial Study Group.
7. Tseng Y.L., Chang Y.Y., Liu J.S., et al. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients. J Neurol Sci 2009, 284:36-39.
8. Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004, 226:25-29.
9. Sachdev P., Parslow R., Salonikas C., et al. Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men. Arch Neurol 2004, 61:1369-1376.
10. Longstreth W.T., Katz R., Olson J., et al. Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Arch Neurol 2004, 61:67-72.
11. Wright C.B., Paik M.C., Brown T.R., et al. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 2005, 36:1207-1211.
12. Seshadri S., Wolf P.A., Beiser A.S., et al. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 2008, 65:642-649.
13. Matsui T., Arai H., Yuzuriha T., et al. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke 2001, 32:1116-1119.
14. Vermeer S.E., van Dijk E.J., Koudstaal P.J., et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 2002, 51:285-289.
15. Wong A., Mok V., Fan Y.H., et al. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease. J Neurol 2006, 253:441-447.
16. Geerlings M.I., Appelman A.P., Vincken K.L., et al. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study. Atherosclerosis 2010, 210:130-136.
17. Anbeek P., Vincken K.L., van Osch M.J., et al. Probabilistic segmentation of white matter lesions in MR imaging. Neuroimage 2004, 21:1037-1044.
18. Schmand B., Geerlings M.I., Jonker C., Lindeboom J. Reading ability as an estimator of premorbid intelligence: does it remain stable in emergent dementia?. J Clin Exp Neuropsychol 1998, 20:42-51.
19. Lezak M.D. Neuropsychological assessment 2004, Oxford University Press, Oxford. 4th ed.
20. van der Griend R., Haas F.J., Duran M., et al. Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med 1998, 132:67-72.
21. Kluijtmans L.A., van den Heuvel L.P., Boers G.H., et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996, 58:35-41.
22. den Heijer M., Blom H.J., Gerrits W.B., et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?. Lancet 1995, 345:882-885.
23. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
24. Hassan A., Hunt B.J., O'Sullivan M., et al. Homocystein is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004, 127:212-219.
25. van Swieten J.C., van den Hout J.H., van Ketel B.A., et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991, 114:761-774.
26. Fazekas F., Schmidt R., Scheltens P. Pathophysiological mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord 1998, 9:2-5.
27. Longstreth W., Manolio T.A., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996, 27:1274-1282.
28. Dufouil C., Alperovitch A., Ducros V., Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003, 53:214-221.
29. Prins N.D., Den Heijer T., Hofman A., et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002, 59:1375-1380.